The Naproxen Test as a Diagnostic Tool in the Causative Differentiation of Fever
|
|
- Theresa Carpenter
- 6 years ago
- Views:
Transcription
1 The Naproxen Test as a Diagnostic Tool in the Causative Differentiation of Fever Emmanuel Edwin R. Dy, M.D.,* Patrick Gerard L. Moral, M.D.** and Sandra Teresa G. Victorio-Navarra, M.D.*** (*Fellow, Section of Infectious and Tropical Medicine, Division of Medicine, **Resident Physician, Division of Medicine and ***Assistant Professor of Medicine, Faculty of Medicine and Surgery, University of Santo Tomas) ABSTRACT The naproxen test was administered to 78 patients who fulfilled the following criteria: (1) fever of at least 38.3 C; (2) duration of at least 2 weeks; (3) suspected or diagnosed neoplastic, connective tissue and infectious causes by history, physical examination and laboratory or ancillary procedures; and (4) there should have been no antimicrobial intake for at least 48 hours prior to the performance of the test. The subjects were given naproxen sodium, 500 mg/tablet, one tablet every 12 hours for 2 days. Fever lysis after or within the time frame of drug administration was interpreted as suggestive of either a neoplastic or a connective tissue disease. Non-response to the regimen was interpreted as suggestive of an infectious condition. Fifty-two (67%) of the 78 patients (67%) responded to the naproxen test. Thirty-seven patients were diagnosed to have either a malignant condition (33) or a connective tissue disease (4). Of these, 31 (98%) with malignancy and 4 (100%) with connective tissue diseases responded to the test with fever lysis. Forty-one patients were initially diagnosed to have infectious conditions; 24 of whom did not respond to the test, yielding a sensitivity of 58.5% for infection. All were later proven to have an infectious condition. This study clearly showed that the test is a very useful tool in detecting malignancy and connective tissue disease as the etiology of prolonged fever. (Phil J Microbiol Infect Dis 1999; 28(3):85-90) Key words: Naproxen test, prolonged fever INTRODUCTION Fever of whatever etiology still remains a perplexing problem to both clinicians and investigators. Increasingly, its role in connective tissue diseases, malignancies and other inflammatory disorders is slowly supplanting the exclusivity of the symptom to just infectious conditions. The identification of the cause of fever is crucially dependent upon meticulous history taking and thorough physical examination coupled with useful ancillary and laboratory procedures. A dilemma arises when the diagnostic aids do not provide the expected results. Subjecting the patient to more laboratory examinations may provide an ordeal rather than a diagnosis. Shotgun antimicrobial therapy may result in a superinfection rather than a cure. The need to categorize prolonged fever in terms of specific etiology is essential in establishing a direction for the clinician's plan of action. Clinical studies have shown that the most common causes of prolonged fever are infections and neoplasms. Based on this premise, the naproxen test may provide a simple and economical tool in the causative differentiation of fever. A seven-year study by Chang confirmed the naproxen test value in differentiating between infections and neoplasms. Lysis of fever upon administration of the drug favors a presumptive diagnosis of neoplastic fever. On the other hand, failure points to an infectious cause. This study aims to: (1) determine the sensitivity of the naproxen test; and (2) identify the most common neoplastic and collagen vascular diseases, which responded unequivocally to the naproxen test.
2 MATERIALS AND METHODS All patients with prolonged fever were included in this study based on the following criteria: (1) fever of at least 38.3 C; (2) duration of at least two weeks; (3) suspected or diagnosed neoplastic, connective tissue and infectious cases through history, physical examination and laboratory or ancillary procedures (complete blood count, urinalysis, chest X-ray, malarial smear, blood culture and biopsy). In addition, there should have been no antimicrobial intake for at least 48 hours prior to the naproxen test. The patients were given naproxen sodium at 500 mg/tablet, one tablet every 12 hours p.c. for a total of 4 doses. Body temperature was taken orally every two hours prior to, during and after the therapeutic trial noting any change in the temperature curve. Naproxen administration was discontinued if any of the following were noted: (1) hypersensitivity reaction, (2) abdominal complaints, or (3) patient refusal to take the drug. Fever lysis after or within the time frame of drug administration was interpreted as suggestive of either a neoplastic condition or a connective tissue disease. This was further verified with the reappearance of fever upon naproxen discontinuation. Non-response of the fever to the drug was taken to suggest an infectious condition. The final diagnosis if not yet established at the time of the test was pursued based on biopsy and/or culture of accessible organs/fluids as well as accompanying diagnostic laboratory examinations and ancillary procedures. Sensitivity of the naproxen test in recognizing malignancy or connective tissue disease was determined. Sensitivity expresses the likelihood of a positive test result in a person with a disease. This is also termed as the true positive rate (TPR). Sensitivity = Number of positive test responders with either malignancy or connective tissue disease/number diagnosed to have malignancy or connective tissue disease RESULTS Seventy-eight patients were included in the study. There were 46 males (60%) and 32 females (40%), with the mean age of 34.2 years, ranging from 7 to 76. The duration of fever ranged from two weeks to one hundred four weeks with temperature ranging from 38.3 C to 42 C, with a mean of 39 C. Thirty three (43%) of the study group was diagnosed to have a malignancy, 4(5%) with connective tissue disease and 41 (52%) with an infectious disease. No patient experienced any untoward side effects. Table 1 shows the overall response of the patients. Thirty five (45%) of the population consisted of true positive responders, 17 (22%) with false positive response, 24 (30%) with true negative response and only 2 (3%) with a false negative response. The thirty-five patients with a true positive response had a mean age of 38.4 years old with a range of seven to seventy years of age. There were 17 males and 18 females. Mean temperature was 38.8 C ranging from 38.3 C to 40 C. Mean duration of fever was eight weeks with a range of three to twenty eight weeks. The earliest response to naproxen test was noted as two hours and the latest was at six hours. Of the true positive responders, 8 neoplastic cases and 2 cases of connective tissue disease were placed on continuous naproxen therapy. All subjects were noted to have drenching sweats upon lysis of fever. The cases comprising the true positive group are as follows: malignant lymphoma (9), pulmonary carcinoma (4), pancreatic malignancy (3), hepatocellular carcinoma (3), multiple myeloma (2), retroperitoneal sarcoma (2), Still's disease (2), carcinomatosis (1), choriocarcinoma (1), undiagnosed malignancy (1), juvenile rheumatoid arthritis (1), systemic lupus erythematosus (1). Table 2 shows seventeen subjects (22%) with false positive response had a mean age of 32 years with a range of 13 to 69 years. There were more males (11) than females (6). The
3 average duration of fever was at 4.5 weeks. The earliest onset of response was noted at two hours. No drenching sweats were noted. The cases comprising this group were as follows: enteric fever (8), amoebic liver abscess (2), extrapulmonary tuberculosis (2), recurrent urinary tract infection (1), pulmonary tuberculosis (1), malaria (1), viral hepatitis (1) and pneumonia (1). Table 1. Diagnostic categories of unequivocal positive responders* to naproxen test Diagnostic Category No. (%) Malignancy 31 (40%) Carcinomatosis 1 Multiple myeloma 2 Malignant lymphoma 9 Pancreatic carcinoma 3 Hepatocellular carcinoma 3 Pulmonary carcinoma 4 Choriocarcinoma 1 Common bile duct carcinoma 1 Leukemia 1 Retroperitoneal sarcoma 2 Malignant astrocytoma 1 Colonic malignancy 1 Ductal carcinoma 1 Undiagnosed malignancy 1 Connective Tissue Disease 4 (5%) Still's disease 2 Juvenile rheumatoid arthritis 1 Systemic lupus erythematosus 1 *Unequivocal positive response refers to fever lysis after naproxen administration verified by recurrence of fever after drug was discontinued. Table 3 shows 24 subjects (30%) who manifested with a true negative response had a mean age of 41.9 years ranging from 11 to 76 years. There were more males (17) than females (7). Mean temperature was at 39.2 C with the lowest temperature at 38.3 C and the highest at 40.7 C. Mean duration of fever was four weeks. Patients belonging to this group were diagnosed to have enteric fever (12), malaria (9), influenza (2) and extrapulmonary tuberculosis (1). Table 2. Diagnostic categories of equivocal responses* to naproxen test Diagnostic Category False Positive False Negative Malignancy 2 (3%) Carcinomatosis 1 Retroperitoneal sarcoma 1 Infectious Disease 17 (22%) Recurrent UTI 1 Enteric fever 8 PTB 1 Amoebic liver abscess 2 Extrapulmonary TB 2 Malaria 1 Influenza - Viral Hepatitis 1 Pneumonia 1 *Refers to either persistence of fever despite drug administration or coincidental disappearance of fever i.e. fever did not recur after discontinuation of the drug. Only 2 subjects with malignancies (3%) gave a false negative response to the naproxen test. These patients each had carcinomatosis and retroperitoneal sarcoma. Of the 2, the latter had a
4 documented urinary tract infection that could account for the absence of response. The diffuse distribution of the former neoplastic condition explained the persistently negative naproxen test. Table 3. Diagnostic categories of unequivocal negative responders* to naproxen test Diagnostic Category No. (%) Infectious Diseases 24 (30%) Enteric fever 12 Extrapulmonary tuberculosis 1 Malaria 9 Influenza 2 *Refers to persistence of fever despite the administration of naproxen Chest X-ray, lymph node and bone marrow biopsy were most useful in establishing malignancy as the cause of prolonged fever. CT scan, ANA titer and C3 level were equally used in the diagnosis of connective tissue diseases for patients with a true positive naproxen test. The naproxen test was most sensitive in recognizing connective tissue diseases and malignancies at 100% and 93.9%, respectively. DISCUSSION In essence, fever represents a disturbance in normal thermoregulation. In health, core body temperature is maintained within a narrow range that varies with the time of day and among individuals. The anterior hypothalamus has a thermostatic mechanism that receives thermal information from both peripheral and central receptors. In fever, an upward displacement of the set point occurs so that the body actively seeks to raise its own temperature. The presence of microorganisms, toxins, neoplasms and inflammation activates mononuclear phagocytes that produce interleukin-1 (IL-1) which in turn raises the thermoregulatory set point in the hypothalamus via prostaglandin E2 (PGE2) 1 synthesis. Resultant increases in heat production and heat conservation produce fever. The neural mediator of the febrile response to IL-1 is believed to be PGE2. IL-1 binds to the surface receptors on target cells in the preoptic region of the anterior hypothalamus, which activates the calcium channels resulting in a net influx of calcium ions into the cell. Increased intracellular calcium initiates the prostaglandin cascade from which the final product is PGE21 (Figure 1). Figure 1. Prostaglandin synthesis 4
5 Fever has long been associated with infection. The offending organism sensitizes inflammatory cells, which results in endogenous pyrogen production. In gram-negative organisms, lipopolysaccharides and lipid A elicit the febrile response. The muramyl dipeptide component of a gram-positive organism's cell wall causes a maximal pyrogenic response. Neoplastic conditions have also been associated with fever. In a study by Browder et al, 2 fever was directly attributed to cancer in at least 5.4% of the patients. The source of endogenous pyrogen in neoplasms is different from infections. Tumor cells have the ability to produce this substance as seen in patients with leukemias, histiocytic lymphomas and Hodgkin's disease. Tumor necrosis factor (TNF alpha type) is another substance identified as a pyrogenic agent. In neoplastic diseases, TNF was synthesized and secreted continuously either by the malignant cells or by immunocompetent cells reacting to the tumor. Beutler 4 hypothesized that TNF may be generated by an inflammatory response to some tumors but that the amount produced is not as spectacular as in bacteremia or septicemia. Connective tissue diseases have fever as one of its common features. In a local study of systemic lupus erythematosus 3, fever was a presenting manifestation in 49% of cases. Connective tissue diseases, either induced by auto-antigens of external stimuli (e.g. drugs) have been known for their heightened systemic inflammatory reactions brought about by the interaction of autoantigens and the antibodies formed against these with the consumption of complement. Non-steroidal anti-inflammatory drugs (NSAIDs) have been used as a diagnostic test for neoplastic conditions. Lysis of the fever implies a neoplastic etiology while failure points to an infectious condition. In a study by Beutler, 4 ibuprofen was administered to experimental animals and humans receiving IFN which was found to attenuate febrile and endocrine responses, probably via the cyclooxygenase pathway. In the study by Dinarello and Wolff, 5, indomethacin was used and the mechanism suggested was that it blocked fever due to a centrally administered muramyl peptide. On the other hand, the drug exerted no effect on the ability of the same pyrogen to stimulate leukocyte endogenous pyrogen production. Neoplasms produce less TNF and subsequently less leukocyte endogenous pyrogen than infectious conditions with the latter causing more prolonged pyrexia, which could not be neutralized adequately by NSAID. Chang 6 evaluated 70 febrile patients in which naproxen showed no antipyretic effect in 14 patients who ultimately turned out to have infections. Failure of NSAID to lyse the fever favors infectious etiologies. In this study, a case of poorly differentiated retroperitoneal sarcoma had a negative response to the naproxen test. The non-defervescence of the fever does not exclude the neoplasm; rather, it could imply a superimposed infectious process that may have been hidden from the initial examinations. Diffuse involvement in the case of carcinomatosis increases TNF production, which could be responsible for the negative response. In a study on fever in neoplastic diseases, complications such as intraabdominal fistulae and cutaneous infections following invasion by the tumor were found to have complicated the situation. 2 A negative test should prod the physician to investigate further for possible coexisting infectious conditions. Enteric fever registered the largest number among false positive responders. Prior antibiotic use, though less than 48 hours in duration, may manifest its therapeutic effect even with a latent period of seven days that may have been falsely attributed to the administration of naproxen. The onset of response to the naproxen test at 2 hours, with the latest at 6 hours was comparable with the study of Chang, wherein the temperature returned to normal within 12 hours. A similar study with the use of indomethacin on visceral cancers resulted in fever lysis within 24 hours. 7 The afebrile state was sustained in all of these studies as long as the patients were maintained on the drug. Continuous naproxen therapy was given to ten of the true positive responders. Those who were not placed on continuous therapy were managed either by surgical means, immunomodulators or chemotherapeutic measures.
6 The naproxen test exhibited no serious side effects especially for short-term use. The test has been applied even to patients with platelet counts above 30,000/uL. Gastrointestinal irritation and anti-platelet effects are associated with long-term use. The naproxen test demonstrated a high sensitivity. In situations of diagnostic uncertainty, it would be better to express this quantitatively and unambiguously by using probability rather than by adjectives such as possibly and probably.8 A clearer direction for the rational use of available ancillary and laboratory procedures is provided by the naproxen test. A negative test in a known neoplastic condition warrants further investigation for a possible infectious source. On the other hand, a positive response points to a neoplastic source of fever, which may remove the need for further work-ups. The naproxen test is a highly sensitive and cost-effective diagnostic aid, which, if interpreted properly, may help to cut down medical expense, alleviate the physician's stress and relieve the patient's discomfort. 8 CONCLUSION AND RECOMMENDATIONS The naproxen test was unequivocally positive in malignancies and connective tissue diseases. Malignant lymphoma was the most common malignancy; only retroperitoneal sarcoma and carcinomatosis yielded a false negative response. Connective tissue diseases included Still's disease, juvenile rheumatoid arthritis and systemic lupus erythematosus. Enteric fever and malaria were the most common infectious diseases with a true negative response. However enteric fever also gave the highest false negative response. Amoebic liver abscess, extrapulmonary tuberculosis, viral hepatitis, pneumonia, recurrent urinary tract infection and pulmonary tuberculosis were the infectious diseases, which responded equivocally to the naproxen test. Other infectious etiologies which gave a true negative response to naproxen test were extrapulmonary tuberculosis and influenza. The likelihood of a positive naproxen test in patients with prolonged fever due to a malignant process or connective tissue disease was high. However, the likelihood of a patient with prolonged fever secondary to an infectious process in a negative naproxen test was minimal. The naproxen test can be used in malignancies and connective tissue diseases either as a diagnostic or therapeutic modality. The test is even more useful in patients with fever of unknown origin, malignancies with superimposed infectious and chronic conditions with developing malignancies. Further validation of the test in a prospective design limited to infections and malignancies with fever lasting for one week or more is currently underway. REFERENCES 1. Rosenthal TC, Silverstein DA. Fever: what to do and what not to do? Postgrad Med 1988; 83 (8): Browder AA, Huff JW, Petersdorf RG. The significance of fever in neoplastic disease. Ann Intern Med 1961; 55 (6): Torralba TP, Victorio STG, Buenviaje MB. Clinical and laboratory features of systemic lupus erythematosus in a Filipino group of patients. Phil J Intern Med 1988, 26: Beutler B. The tumor necrosis factors:cachectin and lymphotoxin. Hosp Practice 1990; Dinarello CA, Wolff SM. Molecular basis of fever in humans. Am J Med 1982; 72: Chang JC. NSAID test to distinguish between infectious and neoplastic fever in cancer patients. Postgrad Med 1988; 84 (8): Warshaw LL, Carey RW, Robinson DR. Control of fever associated with visceral cancers by indomethacin. Surgery 1981; 89(4): Sox, HC Jr. Probability theory in the use of diagnostic tests, an introduction to critical study of the literature. Ann Intern Med 1986; 104:60-66.
Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationEarly Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic
Early Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic Hepatocellular Carcinoma Chih-Hao Shen, MD 3, Jung-Chung Lin, MD, PhD 2, Hsuan-Hwai Lin, MD 1, You-Chen Chao, MD 1, and Tsai-Yuan
More information8/11/16. Kevin Letz DNP, MSN, MBA, RN, CEN, CNE, FNP-C, PCPNP-BC, ANP-BC, FAANP
Kevin Letz DNP, MSN, MBA, RN, CEN, CNE, FNP-C, PCPNP-BC, ANP-BC, FAANP Eosinophilia Eosinophilia refers to an absolute eosinophil count in the peripheral blood of 500 eosinophils/microl; this is considered
More informationNUCLEAR MEDICINE IMAGING IN FUO
NUCLEAR MEDICINE IMAGING IN FUO Christophe Van de Wiele, M.D., Ph.D. Department of Nuclear Medicine, University Hospital, Ghent, Belgium NUCLEAR MEDICINE IMAGING IN FUO Definitions and classifications
More informationnumber Done by Corrected by Doctor موسى العبادي
number 12 Done by Corrected by Doctor موسى العبادي Morphology of Granulomatous Inflammations The first image (left) shows a lung alveolus in which necrosis is taking place. The image below it shows the
More informationWhat is Enbrel? Key features
What is Enbrel? Enbrel (also known by its generic name etanercept) is a biologic medication approved in April 2004 by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe
More informationCytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Understand the physiological
More informationCrohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine
Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight
More informationCHAPTER 11 FEVER. Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University
CHAPTER 11 FEVER Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University DEFINITION OF FEVER Fever is an elevation of body temperature that exceeds the normal daily variation,
More informationFEVER OF UNKNOWN ORIGIN. Cristian Baicus Internal Medicine, Colentina Hospital
FEVER OF UNKNOWN ORIGIN Cristian Baicus Internal Medicine, Colentina Hospital www.baicus.ro 1961 definition 1. Ilness> 3 weeks 2. Fever>38.3 C (>101 F), on several occasions 3. Diagnosis uncertain after
More informationApril 01, Immune system.notebook
I. First Line of Defense: Skin and Mucus Membranes Non Specific A. Skin Surface 1. dry, dead, thick, secretions 2. sweat and sebaceous glands: antibiotics, lactic acid, RNase B. Mucus (moist and sometimes
More information3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis
Chapter 56 Care of the Patient with Cancer All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Cancer Rates in the US 1 in 2 men and 1 in 3 women
More informationDISCLOSURE. Relevant relationships with commercial entities none. Potential for conflicts of interest within this presentation none
FEVER DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and mitigate potential bias N/A LEARNING OBJECTIVE
More informationFever in Lupus. 21 st April 2014
Fever in Lupus 21 st April 2014 Fever in lupus Cause of fever N= 487 % SLE fever 206 42 Infection in SLE 265 54.5 Active SLE and infection 8 1.6 Tumor fever 4 0.8 Miscellaneous 4 0.8 Crucial Question Infection
More informationEBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases
Infectious Disease Definitions Infection when a microorganism invades a host and multiplies enough to disrupt normal function by causing signs and symptoms Pathogencity ability of an organism to cause
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationPhysiology Unit 3. ADAPTIVE IMMUNITY The Specific Immune Response
Physiology Unit 3 ADAPTIVE IMMUNITY The Specific Immune Response In Physiology Today The Adaptive Arm of the Immune System Specific Immune Response Internal defense against a specific pathogen Acquired
More informationPeople maintain normal body temperature despite variations in both their metabolic activity and Ambient temperature Homeothermic animals (hot blooded)
People maintain normal body temperature despite variations in both their metabolic activity and Ambient temperature Homeothermic animals (hot blooded) Animals with body temperature changes with environmental
More informationPathogenesis of Infectious Diseases. CLS 212: Medical Microbiology
Pathogenesis of Infectious Diseases CLS 212: Medical Microbiology Definitions Path- means disease. Pathogenesis The steps or mechanisms involved in the development of a disease. Infection The presence
More informationThe Immune System. These are classified as the Innate and Adaptive Immune Responses. Innate Immunity
The Immune System Biological mechanisms that defend an organism must be 1. triggered by a stimulus upon injury or pathogen attack 2. able to counteract the injury or invasion 3. able to recognise foreign
More informationChapter 32. Non specific (Innate) Host Resistance ( 비특이적 ( 내재 ) 숙주방어 )
Chapter 32 Non specific (Innate) Host Resistance ( 비특이적 ( 내재 ) 숙주방어 ) Host Resistance Overview Immune system ( 면역계 ) Composed of widely distributed cells, tissues, and organs Recognizes foreign substances
More informationDRAFT. Remission rates, calculated using observed case (OC) analyses were as follows: Year 1 Year 2 Year 3 Year 4 All patients 62.
DRAFT New Efficacy Data Shows Cimzia (certolizumab pegol) Provides Long-Term Remission of Moderate to Severe Crohn s Disease Regardless of Prior Anti-TNF Exposure, According to Data Presented at DDW Oral
More informationLYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center
LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells
More informationRadiology Pathology Conference
Radiology Pathology Conference Nadia F. Yusaf, M.D. PGY-3 1/29/2010 Presentation material is for education purposes only. All rights reserved. 2010 URMC Radiology Page 1 of 90 Case 1 60 year- old man presents
More informationTumor Immunology. Tumor (latin) = swelling
Tumor Immunology Tumor (latin) = swelling benign tumor malignant tumor Tumor immunology : the study of the types of antigens that are expressed by tumors how the immune system recognizes and responds to
More informationHYPERSENSITIVITY PNEUMONITIS
HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower
More informationChapter 43. Immune System. phagocytosis. lymphocytes. AP Biology
Chapter 43. Immune System phagocytosis lymphocytes 1 Why an immune system? Attack from outside lots of organisms want you for lunch! animals must defend themselves against unwelcome invaders viruses protists
More informationWARNING: RISK OF SERIOUS INFECTIONS
RA PROGRESSION INTERRUPTED 1 DOSAGE AND ADMINISTRATION GUIDE No structural damage progression was observed at week 52 in 55.6% and in 47.8% of patients receiving KEVZARA 200 mg + MTX or 150 mg + MTX, compared
More informationLung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo
Lung Cancer-a primer Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo CLINICAL CATEGORIES THE SOLITARY PULMONARY NODULE MULTIPLE PULMONARY NODULES Differential Diagnosis Malignant
More informationAll animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity
1 2 3 4 5 6 7 8 9 The Immune System All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity Figure 43.2 In innate immunity, recognition and
More informationNatural Defense Mechanisms
Color code: Important in red Extra in blue For team error adjustments, click here Natural Defense Mechanisms Objectives To know First (non-specific immunity) and second (adaptive immunity) lines of defense
More informationREGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth
REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES R e g i S C A R PATIENT'S DATA Initials of the patient date of birth Age country of birth Gender male female
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationDisease causing organisms Resistance Immunity
Part 1 Disease causing organisms Resistance Immunity Bacteria Most common pathogens Anthrax Cholera Staphylococcus epidermidis bacteria Bacterial diseases Tuberculosis Cholera Bubonic Plague Tetanus Effects
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationResident, PGY1 David Geffen School of Medicine at UCLA. Los Angeles Society of Pathology Resident and Fellow Symposium 2013
Resident, PGY1 David Geffen School of Medicine at UCLA Los Angeles Society of Pathology Resident and Fellow Symposium 2013 85 year old female with past medical history including paroxysmal atrial fibrillation,
More informationHandbook of Nonprescription Drugs: An Interactive Approach to Self Care, 18 th Edition Corrections and Revisions
Handbook of Nonprescription Drugs: An Interactive Approach to Self Care, 18 th Edition Corrections and Revisions Note: All the corrections and revisions have been made on the e version of the book that
More informationHumira. (adalimumab) Drug Update Slideshow NEW INDICATION
Humira (adalimumab) NEW INDICATION Drug Update Slideshow Introduction Brand name: Humira Generic name: Adalimumab Pharmacological class: Tumor necrosis factor (TNF) blocker Strength and Formulation: 10mg/0.2mL,
More informationUnit 5 The Human Immune Response to Infection
Unit 5 The Human Immune Response to Infection Unit 5-page 1 FOM Chapter 21 Resistance and the Immune System: Innate Immunity Preview: In Chapter 21, we will learn about the branch of the immune system
More informationThe role of Electron Microscopy in the study of cytologic specimens. Elba A. Turbat-Herrera, MD
The role of Electron Microscopy in the study of cytologic specimens. Elba A. Turbat-Herrera, MD Louisiana State University Health Sciences Center Shreveport, LA, USA Introduction The field of Cytology
More informationAbstracting Hematopoietic Neoplasms
CASE 1: LYMPHOMA PHYSICAL EXAMINATION 43yo male with a history of lower gastrointestinal bleeding and melena undergoing colonoscopy and biopsy to rule out neoplasm versus inflammation. Patient had no other
More informationFaculty of Veterinary Medicine Universiti Malaysia Kelantan. Immunology and Serology (DVT2153)
Faculty of Veterinary Medicine Universiti Malaysia Kelantan Immunology and Serology (DVT2153) By Dr. Erkihun Aklilu 1 Immune Response AgAinst Various infectious agents Immunology and Serology (DVT2153)
More informationFor questions 1-5, match the following with their correct descriptions. (24-39) A. Class I B. Class II C. Class III D. TH1 E. TH2
Questions Made by SI ATTENDEES!! :) Page 1 of 6 Student-Made Practice Exam Activity All questions, answers, and slide numbers are based off of Monday s SI activity, where students/attendees created possible
More information"The standard treatment for almost all cancers is surgical removal of the lump."
Cancer Treatment As continuous improvements in our knowledge and new and evolving methods of treatment are developed, pet owners and their veterinarians have more options available when cancer is diagnosed.
More informationInnate vs Adaptive Response
General Immunology Innate vs Adaptive Response Innate- non-specific (4 types of barriers) anatomic- ato mechanical ca (skin), ph, mucous, normal flora Physiologic- temperature, ph, chemicals (lysozyme,
More informationSTUDY OF SIGNIFICANCE OF PLATELET COUNT IN FEVER CASES G. Vasavilatha 1, A. K. Murthy 2, P. Kranthi 3, M. Chandrashekhar 4
STUDY OF SIGNIFICANCE OF PLATELET COUNT IN FEVER CASES G. Vasavilatha 1, A. K. Murthy 2, P. Kranthi 3, M. Chandrashekhar 4 HOW TO CITE THIS ARTICLE: G. Vasavilatha, A. K. Murthy, P. Kranthi, M. Chandrashekhar.
More informationNOTOPAIN CAPLETS. Diclofenac Sodium + Paracetamol. Composition. Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg.
NOTOPAIN CAPLETS Diclofenac Sodium + Paracetamol Composition Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg Pharmacology Phamacodynamics Diclofenac relieves pain and inflammation
More information* MILIARY MOTTLING --
* MILIARY MOTTLING -- RARE CAUSE DR ARATHI SRINIVASAN FELLOW IN PEDIATRIC HEMATO ONCOLOGY DR A ANDAL DEPARTMENT OF PEDIATRICS DR JULIUS XAVIER SCOTT DEPARTMENT OF PEDIATRIC HEMATO ONCOLOGY KANCHI KAMAKOTI
More informationCurriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center
MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult
More informationLYMPHOCYTES & IMMUNOGLOBULINS. Dr Mere Kende, Lecturer SMHS
LYMPHOCYTES & IMMUNOGLOBULINS Dr Mere Kende, Lecturer SMHS Immunity Immune- protection against dangers of non-self/invader eg organism 3 components of immune system 1 st line: skin/mucosa/cilia/hair/saliva/fatty
More informationHYPERSENSITIVITY REACTIONS D R S H O AI B R AZ A
HYPERSENSITIVITY REACTIONS D R S H O AI B R AZ A HYPERSENSITIVITY REACTIONS Are exaggerated immune response upon antigenic stimulation Individuals who have been previously exposed to an antigen are said
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationHELPING YOU AND YOUR PATIENTS TALK OPENLY ABOUT MODERATELY TO SEVERELY ACTIVE RA
SIMPONI ARIA (golimumab) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) in combination with MTX, active psoriatic arthritis, and active ankylosing
More informationOverview of the Lymphoid System
Overview of the Lymphoid System The Lymphoid System Protects us against disease Lymphoid system cells respond to Environmental pathogens Toxins Abnormal body cells, such as cancers Overview of the Lymphoid
More informationChronic Lymphocytic Leukemia (CLL)
Page 1 of 10 PATIENT EDUCATION Chronic Lymphocytic Leukemia (CLL) Introduction Chronic lymphocytic leukemia (CLL) is a type of cancer of the lymphocytes (a kind of white blood cell). It is also referred
More informationCOURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16
COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 Tumor Immunology M. Nagarkatti Teaching Objectives: Introduction to Cancer Immunology Know the antigens expressed by cancer cells Understand
More informationMorphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital
Morphology Case Study Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital 41 year old male presented to GP for routine check-up in May 2011. FBC Results:
More informationAP Biology. Why an immune system? Chapter 43. Immune System. Lines of defense. 1st: External defense. 2nd: Internal, broad range patrol
Chapter 43. Immune System lymphocytes attacking cancer cell lymph phagocytic leukocyte Why an immune system? Attack from outside lots of organisms want you for lunch! animals must defend themselves against
More informationSummary of the risk management plan (RMP) for Clopidogrel/Acetylsalicylic acid Teva (clopidogrel / acetylsalicylic acid)
EMA/411850/2014 London, 28 July 2014 Summary of the risk management plan (RMP) for (clopidogrel / acetylsalicylic acid) This is a summary of the risk management plan (RMP) for, which details the measures
More informationAttribution: University of Michigan Medical School, Department of Microbiology and Immunology
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution
More informationCeftizoxime in the treatment of infections in patients with cancer
Journal of Antimicrobial Chemotherapy (98), Suppl. C, 67-73 Ceftizoxime in the treatment of infections in patients with cancer V. Fainstein, R. Bolivar,. Elting, M. Valdivieso and G. P. Bodey Department
More informationBihong Zhao, M.D, Ph.D Department of Pathology
Bihong Zhao, M.D, Ph.D Department of Pathology 04-28-2009 Is tumor self or non-self? How are tumor antigens generated? What are they? How does immune system respond? Introduction Tumor Antigens/Categories
More informationContact Investigation and Prevention in the USA
Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationPulmonary Morning Report. Ashley Schmehl D.O. PGY-3 January,
Pulmonary Morning Report Ashley Schmehl D.O. PGY-3 January, 8 2015 Pleural Effusion Unilateral versus Bilateral Associated symptoms Transudate versus Exudate Light s Criteria: Pleural protein: Serum protein
More informationSummary of Risk Minimization Measures
Table 6.1.4-1: Summary of Risk Minimization Measures Safety Concern Vaccination Hepatic and renal impairment Combination therapy Elderly Routine Risk Minimization Measures Specific subsection on vaccination
More informationCOUGH Dr. A m A it i e t sh A g A garwa w l Le L ctu t rer Departm t ent t o f f M e M dic i in i e
COUGH Dr. Amitesh Aggarwal Lecturer Department of Medicine Cough is an explosive expiration that provides a normal protective mechanism for clearing the tracheobronchial tree of secretions and foreign
More informationGuideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation
Guideline for the Management of Fever Neutropenia in Children with Cancer /or Undergoing Hematopoietic Stem-Cell Transplantation COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationMicrobial Mechanisms of Pathogenicity & Innate Immunity: Nonspecific Defenses of the Host
Microbial Mechanisms of Pathogenicity & Innate Immunity: Nonspecific Defenses of the Host Microbial Mechanisms of Pathogenicity Pathogenicity: Virulence: The extent of pathogenicity. - function of: - infectivity
More informationCancer Awareness Talk ICPAK 2014
Cancer Awareness Talk ICPAK 2014 F. Chite Asirwa, MB ChB. MD. MSc. Internist. Medical Oncologist & Hematologist Asst. Professor of Medicine Division of Hematology/Oncology Indiana University Email: fasirwa@iu.edu
More informationCorticosteroids. Veterinary Pharmacology Endocrine System. University of Tehran Faculty of Veterinary Medicine Academic Year
Veterinary Pharmacology Endocrine System Corticosteroids University of Tehran Faculty of Veterinary Medicine Academic Year 2008-9 Goudarz Sadeghi, DVM, PhD, DSc Associate Professor of Pharmacology Introduction
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationThe Frequency and Significance of Small (15 mm) Hepatic Lesions Detected by CT
535 Elizabeth C. Jones1 Judith L. Chezmar Rendon C. Nelson Michael E. Bernardino Received July 22, 1991 ; accepted after revision October 16, 1991. Presented atthe annual meeting ofthe American Aoentgen
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationStudy of demographic features of abdominal tuberculosis in Urban population in Pune
Original article: Study of demographic features of abdominal tuberculosis in Urban population in Pune 1 Dr. J.S Dhadwad*, 2 Dr. Akshay Shewale 1Associate Professor in Medicine, Pad.Dr.DY Patil Medical
More informationA Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014
A Practical Approach to Leukopenia/Neutropenia in Children Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014 Disclosures EPIC trial MAST Therapeutics SUSTAIN trial Selexys Pharmaceuticals
More information2.0 Synopsis. Adalimumab DE019 OLE (5-year) Clinical Study Report Amendment 1 R&D/06/095. (For National Authority Use Only)
2.0 Synopsis Abbott Laboratories Name of Study Drug: Humira Name of Active Ingredient: Adalimumab Individual Study Table Referring to Part of Dossier: Volume: Page: (For National Authority Use Only) Title
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationUpper Respiratory Tract Infections
Upper Respiratory Tract Infections OTITIS MEDIA Otitis media is an inflammation of the middle ear. There are more than 709 million cases of otitis media worldwide each year; half of these cases occur in
More informationChronic non-bacterial Osteomyelitis/Osteitis (or CRMO)
www.printo.it/pediatric-rheumatology/gb/intro Chronic non-bacterial Osteomyelitis/Osteitis (or CRMO) Version of 2016 1. WHAT IS CRMO 1.1 What is it? Chronic Recurrent Multifocal Osteomyelitis (CRMO) is
More informationNew Cimzia data, with sites in the US, demonstrate safety and efficacy, increased participation in social activities for adult RA patients
Long-term Cimzia (certolizumab pegol) data demonstrated rapid sustained improvements in clinical outcomes and quality of life in moderate to severe rheumatoid arthritis (RA) patients New Cimzia data, with
More informationTUBERCULOSIS. Pathogenesis and Transmission
TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are
More informationClinical, Diagnostic, and Operative Correlation of Acute Abdomen
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/163 Clinical, Diagnostic, and Operative Correlation of Acute Abdomen Madipeddi Venkanna 1, Doolam Srinivas 2, Budida
More informationChapter 25. Learning Objectives. Learning Objectives (Cont d) 9/10/2012. Immune System Disorders
Chapter 25 Immune System Disorders Learning Objectives Review specific anatomy and physiology of the immune system, pathophysiology pertinent to immune system disorders Describe characteristics of the
More informationLiver Disease. By: Michael Martins
Liver Disease By: Michael Martins Recently I have been getting a flurry of patients that have some serious liver complications. This week s literature review will be the dental management of the patients
More information~ons~ecific Bod~ Defenses and Immunity
~ons~ecific Bod~ Defenses and Immunity The human body continually attempts to maintain homeostasis by counteracting harmful or disease-producing organisms called pathoqens or the toxins they produce. The
More informationWhat prescribers need to know
HUMIRA Citrate-free presentations in an Electronic Medical Record (EMR) What prescribers need to know 2 / This is your guide to identifying HUMIRA Citrate-free presentations in your Electronic Medical
More informationInternal Medicine Certification Examination Blueprint
Internal Medicine Certification Examination Blueprint What Does the Examination Cover? The exam is designed to evaluate the extent of the candidate s knowledge and clinical judgment in the areas in which
More informationThe London Gastroenterology Partnership CROHN S DISEASE
CROHN S DISEASE What is Crohn s disease? Crohn s disease is a condition, in which inflammation develops in parts of the gut leading to symptoms such as diarrhoea, abdominal pain and tiredness. The inflammation
More informationMast Cell Tumors in Dogs
Mast Cell Tumors in Dogs 803-808-7387 www.gracepets.com These notes are provided to help you understand the diagnosis or possible diagnosis of cancer in your pet. For general information on cancer in pets
More informationAgeing and the burden of diseases in the elderly. Karl-Heinz Krause Geneva University Hospitals and Medical Faculty
Ageing and the burden of diseases in the elderly Karl-Heinz Krause Geneva University Hospitals and Medical Faculty - Norwegian Surveillance System for Communicable Diseases (MSIS) - Clinicians and laboratories
More informationChildren Enteric coated tablet : 1-3 mg/kg per day in divided doses.
Ultrafen Tablet/SR Tablet/Suppository/Gel Description Ultrafen is a preparation of Diclofenac is a non-steroidal antiinflammatory agent with marked analgesic, anti-inflammatory and antipyretic properties.
More informationChapter 13 Lecture Outline
Chapter 13 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationInformed Consent for Liver Transplant Patients
Informed Consent for Liver Transplant Patients Evaluation Process You will be evaluated with consultations, lab tests and various procedures to determine the medical appropriateness of liver transplant.
More informationLines of defense. Innate Immunity. Immunity. First line of defense: Skin and mucous membranes 11/20/2016. Chapter 16 BIO 220
Lines of defense Innate Immunity Chapter 16 BIO 220 Immunity The ability to ward off disease caused by microbes or their products and to protect against environmental agents such as pollen, chemicals,
More informationBlood and Immune system Acquired Immunity
Blood and Immune system Acquired Immunity Immunity Acquired (Adaptive) Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated
More informationClassification of Neoplasms
Classification of Neoplasms ICD-10 Chapter 2, Neoplasms Codes C00-D48 Notes at beginning of Chapter 2 Classified by behaviour and site Correct use of Alphabetic index required Main terms Modifiers Table
More informationFever in Children. Sue Moore APRN, ENP-C (almost retired)
Fever in Children Sue Moore APRN, ENP-C (almost retired) Topics Definiton Taking the temp Function of fever Reasons for treating fever How antipyretics work Fever: Temperature over 38 C Taking the Temp
More information